Loading

AMGN — AMGEN INC · PureTicker

Dashboard Screener Smart Money Ask

More▾

Chart read News S&P 500 Pricing Methodology

☰✕

Dashboard Screener Smart Money Ask

Chart read News S&P 500 Pricing Methodology

AMGN

AMGEN INCB7215-min delayed · EOD close

391.27▼ −0.48% downas of 2026-09-09mkt cap $212B

Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0000318154

Key Stats Financials Fair Value Quality Technicals Peers Smart Money Ratings News

Chart read News S&P 500 Pricing Methodology Terms Privacy

Research and education only. Not investment advice, not a broker or registered adviser, and no trade execution. Data from SEC EDGAR and Yahoo Finance.

Market cap

$212B

P/E

24.2

Net margin

23.0%

ROE

74.8%

Revenue

$38.1B

latest annual

Net income

$8.7B

latest annual

Shares out

541M

Free cash flow

$10.2B

52-week range

Current: 391.27

▲

Low

263.72

High

444.12

Quality score

72/100

B

Growth74

Business quality92

missing: grossMargin

Financial healthno data

missing: debtToEquity, cashToLiabilities

Valuation48

Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.